Oxolamine
Systematic (IUPAC) name | |
---|---|
N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
CAS number | 959-14-8 |
ATC code | R05DB07 |
PubChem | CID 13738 |
ChemSpider | 13143 |
UNII | 90BEA145GY |
KEGG | D07387 |
ChEMBL | CHEMBL1620875 |
Chemical data | |
Formula | C14H19N3O |
Mol. mass | 245.32 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Oxolamine is a cough suppressant.
Synthesis
The syntheses of 1,2,4-oxadiazole systems all rely on hydroxylamine for providing a preformed N-O linkage. The preparation of the respiratory anti-inflammatory and antitussive agent oxolamine starts by acylation of the alkoxide from the N-hydroxyamidine with 3-chloropropionyl chloride; the presence of the negative charge on oxygen results in the formation of the O-acylated product. Treatment of that intermediate with triethylamine leads to cyclization via imine formation to afford the 1,2,4-oxadiazole. Displacement of the terminal chlorine with diethylamine gives the corresponding amine oxolamine.
|